lu.se

Experimentell medicinsk vetenskap

Medicinska fakulteten | Lunds universitet

Meny

Institutionen för Experimentell Medicinsk Vetenskap

Institutionen för Experimentell Medicinsk Vetenskap, EMV, har som uppgift att bedriva forskning på molekylär, cellulär och integrativ nivå rörande de livsprocesser som bestämmer kroppens funktion, normalt och vid sjukdom.


Åsa Petersén och Karl Swärd installerades som professorer i medicinsk forskning med inriktning mot neurovetenskap resp fysiologi den 14 oktober vid Lunds universitet. Läs vad de själva skriver om sin forskning.

The NYSCF (New York Stem Cell Foundation) Investigator Program främjar och uppmuntrar lovande unga forskare vars banbrytande forskning har potential att påskynda behandlingar och botemedel.

Maria Swanberg

It is well known that around 90% of all Parkinson's disease cases are idiopathic, hence caused by a combination of environmental and genetic risk factors. Strategies to identify genetic risk factors in humans, e.g. by GWAS, have yielded important insight into the genetic landscape of Parkinson's disease. However, estimates are that 40% of the population risk is attributed to so far unidentified genetic risk factors. Our strategy to increase the understanding of genetic risk factors, and hence etiology, of Parkinson's disease is to genetically map key neuropathological processes by linkage in an experimental mouse model.

Defences of doctoral theses Dept of Experimental Medical Science, September 2016: Andrew  McCourt – Biomedicine, Neuroscience, Zandra Körner – Biomedicine, Cell and Matrix Biology, Staffan Holmqvist - Biomedicine, Neuroscience and Sandra Cuellar Baena - Biomedicine, Neuroscience.

Defences of doctoral theses - Emil Tykesson in Biomedicine, Cell and Matrix Biology. Time and place: 2016-05-25, 09:00 in Belfragesalen, BMC D15, Klinikgatan 32, Lund. Main supervisor: Prof. Gunilla Westergren-Thorsson Opponent: Prof. Jian Liu, UNC Eshelman School of Pharmacy, USA. Chairman: Prof. Hakon Leffler
 
Welcome!